100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE Anti-Mouse CD45.1 Antibody [A20] (AGEL1949)

SKU AGEL1949
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Mouse
Applications FC
€50 - €173

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Mouse CD45.1 Antibody [A20]

The Mouse CD45.1 Monoclonal Antibody PE Conjugated (A20) is a powerful tool for researchers studying immune cells in mouse models. This antibody specifically targets the CD45.1 antigen, a marker for certain subsets of immune cells, including T cells and B cells. The PE conjugation allows for easy and efficient detection of CD45.1-positive cells using flow cytometry, a widely used technique in immunology research. With the A20 clone, researchers can confidently identify and analyze immune cell populations in mouse samples.The CD45.1 antigen is essential for understanding immune cell development, activation, and function in mouse models.

By using this monoclonal antibody, researchers can gain valuable insights into the role of specific immune cell subsets in various immune responses, autoimmune diseases, and tumor immunity in preclinical studies.Overall, the Mouse CD45.1 Monoclonal Antibody PE Conjugated (A20) is a reliable tool for researchers aiming to elucidate the intricate mechanisms of the immune system in mouse models, paving the way for advancements in immunology and potentially leading to new therapeutic strategies for immune-related diseases.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose